Potential role of extracellular vesicles from different sources in unexplained recurrent pregnancy loss
Authors:
- 22 December 2025
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 114 (3) , 744-754
Abstract
Unexplained recurrent pregnancy loss (URPL) is complex and has unknown etiologies, simultaneously endangering the patient's physical and mental health. Despite significant advancements in shifting from conventional treatments to cell therapy, clinical research and application in cell therapy have been constrained by its immunogenic properties and biosafety. As a new cell–cell communication pathway, extracellular vesicles (EVs) can transfer their bioactive cargos to other cells by endocytosis, ligand-receptor engagement, or direct fusion, thereby executing diverse biological functions both in proximity and across great distances. It is noteworthy that the role of EVs as a cell-free therapy in the form of a drug transporter has garnered increased attention, and some studies have demonstrated EVs involvement in the key pathology of URPL. This review methodically summarizes the functions of EVs from various sources in URPL, including mesenchymal stem cells, placenta, and other sources of EVs. Furthermore, we discuss the significance of EVs as possible diagnostic biomarkers and therapeutic strategies for URPL and the key questions that need to be addressed in future research.Keywords
Funding Information
- National Natural Science Foundation of China (82360306)
- National Natural Science Foundation of China (82160295)
- Guangxi Medical University Training Program for Distinguished Young Scholars
This publication has 106 references indexed in Scilit:
- Extracellular Vesicles, Lipid Droplets and AhR Ligands in Early Implantation: The Dynamics of Embryo‐Maternal CrosstalkJournal of Extracellular Vesicles, 2025
- Gene Therapy for Inflammatory Cascade in Intrauterine Injury with Engineered Extracellular Vesicles Hybrid Snail Mucus‐enhanced Adhesive HydrogelsAdvanced Science, 2024
- Targeting Decidual CD16 + Immune Cells with Exosome‐Based Glucocorticoid Nanoparticles for MiscarriageAdvanced Science, 2024
- Extracellular vesicles from seminal plasma interact with T cells in vitro and drive their differentiation into regulatory T‐cellsJournal of Extracellular Vesicles, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Decidual CXCR4+CD56brightNK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failureClinical and Translational Medicine, 2021
- Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery StrategiesAdvanced Healthcare Materials, 2021
- Paternal contributors in recurrent pregnancy loss: Cues from comparative proteome profiling of seminal extracellular vesiclesMolecular Reproduction and Development, 2020
- Mesenchymal stem cells‐derived exosomes improve pregnancy outcome through inducing maternal tolerance to the allogeneic fetus in abortion‐prone mating mouseThe Kaohsiung Journal of Medical Sciences, 2020
- Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage PolarizationStem Cells Translational Medicine, 2017